Atara Biotherapeutics's total assets for Q3 2025 were $30.17M, a decrease of -18.25% from the previous quarter. ATRA total liabilities were $66.80M for the fiscal quarter, a -7.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.